Filed: Jan. 20, 2015
Latest Update: Mar. 02, 2020
Summary: Case: 14-12144 Date Filed: 01/20/2015 Page: 1 of 11 [PUBLISH] IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT _ No. 14-12144 _ D.C. Docket No. 1:14-cv-00810-WSD LABMD, INC., Plaintiff - Appellant, versus FEDERAL TRADE COMMISSION, Defendant - Appellee. _ Appeal from the United States District Court for the Northern District of Georgia _ (January 20, 2015) Case: 14-12144 Date Filed: 01/20/2015 Page: 2 of 11 Before MARTIN and ANDERSON, Circuit Judges, and COTE, * District Judge. MA
Summary: Case: 14-12144 Date Filed: 01/20/2015 Page: 1 of 11 [PUBLISH] IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT _ No. 14-12144 _ D.C. Docket No. 1:14-cv-00810-WSD LABMD, INC., Plaintiff - Appellant, versus FEDERAL TRADE COMMISSION, Defendant - Appellee. _ Appeal from the United States District Court for the Northern District of Georgia _ (January 20, 2015) Case: 14-12144 Date Filed: 01/20/2015 Page: 2 of 11 Before MARTIN and ANDERSON, Circuit Judges, and COTE, * District Judge. MAR..
More
Case: 14-12144 Date Filed: 01/20/2015 Page: 1 of 11
[PUBLISH]
IN THE UNITED STATES COURT OF APPEALS
FOR THE ELEVENTH CIRCUIT
________________________
No. 14-12144
________________________
D.C. Docket No. 1:14-cv-00810-WSD
LABMD, INC.,
Plaintiff - Appellant,
versus
FEDERAL TRADE COMMISSION,
Defendant - Appellee.
________________________
Appeal from the United States District Court
for the Northern District of Georgia
________________________
(January 20, 2015)
Case: 14-12144 Date Filed: 01/20/2015 Page: 2 of 11
Before MARTIN and ANDERSON, Circuit Judges, and COTE, ∗ District Judge.
MARTIN, Circuit Judge:
LabMD, Inc. is an Atlanta-based laboratory that performed cancer-detection
testing services for doctors. After the Federal Trade Commission (FTC)
discovered that LabMD patient information files were available on a peer-to-peer
file-sharing network, it launched an investigation into LabMD’s data-security
practices. The investigation persisted for three years, leading LabMD’s CEO,
Michael Daugherty, to publicly criticize the FTC’s actions. Shortly after Mr.
Daugherty posted an online trailer for his book, “The Devil Inside the Beltway,”
which he says exposes corruption in the federal government, the FTC filed an
administrative complaint against the company. The administrative proceeding is
ongoing.
This appeal addresses the District Court’s dismissal of LabMD’s challenges
to the FTC’s ability to regulate and conduct enforcement proceedings in the area of
healthcare data privacy. LabMD argues that the FTC’s enforcement action violates
the Administrative Procedure Act (APA), is ultra vires, and is unconstitutional.
Before we can reach the merits of LabMD’s claims, we must first face the
central question of whether the District Court has subject-matter jurisdiction to
consider LabMD’s challenges while the administrative proceeding is ongoing.
∗
Honorable Denise Cote, United States District Judge for the Southern District of New York,
sitting by designation.
2
Case: 14-12144 Date Filed: 01/20/2015 Page: 3 of 11
Because we hold that the FTC’s Order denying LabMD’s motion to dismiss was
not a “final agency action,” as is required of claims made under the APA, those
claims were properly dismissed. And because we conclude that LabMD’s other
claims—that the FTC’s actions were ultra vires and unconstitutional—are
intertwined with its APA claim for relief and may only be heard at the end of the
administrative proceeding, we affirm the District Court’s order dismissing the case
for lack of subject-matter jurisdiction.
I.
In 2008, internet-security company Tiversa, Inc. notified LabMD that it had
obtained sensitive patient information from LabMD. Under circumstances that
remain hotly disputed by the parties, the FTC learned about the possible breach of
security involving patient information and began an investigation into LabMD’s
data-security practices in 2010. On July 19, 2013, Mr. Daugherty posted an online
trailer to his book highlighting corruption in the federal government, including
specific claims about the FTC. Three days after Mr. Daugherty posted the trailer
online, the FTC gave notice of its intent to file a complaint against LabMD.
In August 2013, the FTC filed its administrative complaint, alleging that
LabMD violated Section 5 of the FTC Act by engaging in an “unfair . . . act[] or
practice[]” by failing to prevent unauthorized access to its patient information.
LabMD moved to dismiss the FTC Complaint, which the FTC denied in a January
3
Case: 14-12144 Date Filed: 01/20/2015 Page: 4 of 11
2014 Order. LabMD next filed suit in the District Court for the District of
Columbia, seeking an injunction to stay the administrative action from going
forward on the grounds that it was an improper expansion of FTC jurisdiction, was
retaliatory, and violated the Due Process Clause. LabMD v. FTC, No. 1:13-cv-
1787 (D.D.C. Nov. 14, 2013). LabMD filed a similar action in this Court, making
the same allegations. LabMD Inc. v. FTC, No. 13-15267-F (11th Cir. Feb. 18,
2014). We denied LabMD’s claim, citing our lack of jurisdiction over a non-final
agency action, but we declined to address whether the District Court could hear
any of the claims.
Id. LabMD voluntarily dismissed its District of Columbia suit.
On March 20, 2014, LabMD filed this suit in the Northern District of
Georgia, alleging that: (1) the FTC’s administrative action against LabMD is
arbitrary and capricious in violation of the APA because the FTC has no authority
to regulate protected health information (PHI); (2) the action is ultra vires and
exceeds its statutory authority; (3) the FTC’s application of Section 5 to LabMD’s
security protocols violates the Due Process Clause of the U.S. Constitution because
it did not provide fair notice or access to a fair tribunal and a hearing; and (4) the
FTC violated LabMD’s First Amendment right to free speech. The FTC filed a
motion to dismiss, which the District Court granted.
4
Case: 14-12144 Date Filed: 01/20/2015 Page: 5 of 11
II.
We review de novo a district court’s grant of a motion to dismiss for lack of
subject-matter jurisdiction. Cash v. Barnhart,
327 F.3d 1252, 1255 n.4 (11th Cir.
2003) (per curiam). The District Court dismissed LabMD’s APA claim for lack of
subject-matter jurisdiction because the FTC’s Order denying dismissal was not a
final order. The District Court also dismissed the related constitutional and ultra
vires claims as premature. We first turn to LabMD’s challenge under the APA.
LabMD argues that the Complaint and Order were sufficiently final to confer
subject-matter jurisdiction over its APA claim. We cannot agree.
According to the APA, “final agency action for which there is no other
adequate remedy in a court [is] subject to judicial review.” 5 U.S.C. § 704.
Absent a final action, the courts are to exercise restraint so that the administrative
agency may correct any errors by conducting its own internal appeals and by
applying its own institutional expertise. The Supreme Court has held that an action
must satisfy two requirements to be final: “First, the action must mark the
consummation of the agency’s decisionmaking process—it must not be of a merely
tentative or interlocutory nature. And second, the action must be one by which
rights or obligations have been determined, or from which legal consequences will
flow.” Bennett v. Spear,
520 U.S. 154, 177–78,
117 S. Ct. 1154, 1168 (1997)
(internal citations and quotation marks omitted).
5
Case: 14-12144 Date Filed: 01/20/2015 Page: 6 of 11
Under the Bennett standard, the Order and Complaint LabMD seeks to have
us review are not final. First, neither document is a consummation of the agency’s
decisionmaking process. LabMD suggests that these documents “effectively
determined there would be legal consequences imposed on LabMD,” because the
filing of an FTC complaint almost certainly leads to a cease-and-desist order. But,
high odds of a cease-and-desist order coming from the FTC do not advance our
ability to review the FTC actions. It is the nature of the action we must consider,
and the Complaint and Order do not finally decide these issues. By definition, the
denial of a motion to dismiss ensures that the proceeding will continue to a later,
final order. In the same way, a complaint is just an initial document.
Next, no “direct and appreciable legal consequences” flowed from either
FTC action, and “no rights or obligations have been determined,” because the
agency proceeding is ongoing. See
Bennett, 520 U.S. at 178, 117 S. Ct. at 1168–
69. LabMD argues that, on two occasions, the FTC characterized its Order as
final, and therefore we must accept it as such. First, the FTC described its Order
here as a “definitive interpretation of the application of Section 5.” Second, the
FTC sought Chevron 1 deference for this Order in another case. See FTC v.
Wyndham Worldwide Corp.,
10 F. Supp. 3d 602, 615 n.8 (D.N.J. 2014). True as
1
Chevron U.S.A., Inc. v. Natural Res. Def. Council, Inc.,
467 U.S. 837,
104 S. Ct. 2778 (1984).
Chevron deference is afforded only to final agency actions operating with the force and effect of
law, Christenson v. Harris Cnty.,
529 U.S. 576, 587,
120 S. Ct. 1655, 1662–63 (2000).
6
Case: 14-12144 Date Filed: 01/20/2015 Page: 7 of 11
this may be, we are not required to agree with the FTC’s characterization of its
own Order in the course of litigation. See, e.g., Inv. Co. Inst. v. Camp,
401 U.S.
617, 628,
91 S. Ct. 1091, 1097–98 (1971); William Bros. v. Pate,
833 F.2d 261,
265 (11th Cir. 1987) (“[W]e do not agree that the [agency’s] mere litigating
position is due to be given deference. . . . [T]he Supreme Court has on a number of
occasions proscribed granting deference to a litigating position . . . .”). And while
it would be notable that some other court had afforded Chevron deference to the
FTC's Order—because that would imply a finding of finality—the court in the case
proffered by LabMD did not afford Chevron deference. The FTC merely asked for
it.
Even though the Supreme Court has previously held that an FTC complaint
is not final agency action, see FTC v. Standard Oil Co. of Cal.,
449 U.S. 232, 239,
101 S. Ct. 488, 493 (1980), LabMD suggests that its challenge to the FTC’s
jurisdiction can be heard at this early stage in the administrative proceeding
because it falls within an exception to Standard Oil. Later circuit court cases
interpreting Standard Oil suggest that its holding does have limited exceptions
which would allow district court review of administrative actions. See, e.g.,
Athlone Indus., Inc. v. Consumer Prod. Safety Comm’n,
707 F.2d 1485, 1489 &
n.30 (D.C. Cir. 1983) (recognizing an exception to the exhaustion requirement and
permitting district court review of an agency’s authority to impose civil penalties);
7
Case: 14-12144 Date Filed: 01/20/2015 Page: 8 of 11
CSI Aviation Servs., Inc. v. U.S. Dep't of Transp.,
637 F.3d 408, 412–13 (D.C. Cir.
2011) (holding that a Department of Transportation warning letter and exemption
order were sufficiently “final” because they (1) included a definitive statement that
the plaintiff’s business was violating the Federal Aviation Act; (2) presented a
“purely legal” question with no factual disputes; and (3) imposed an immediate
burden by effectively requiring the business to stop operating). Even if those
exceptions applied in this Circuit, LabMD’s challenge here does not fit within their
terms. As set forth in our discussion above, the FTC Complaint and Order are not
sufficiently definitive, cleanly legal, or immediately burdensome so as to require
our review at this stage. The FTC is best suited to develop the factual record,
continue to evaluate its position on the issues, and apply its expertise to complete
the proceeding. All of this will allow for more robust appellate review by this
Court when the action concludes.
III.
LabMD next suggests that its constitutional and ultra vires claims can be
heard even if we do not reach the APA claim. But under similar circumstances, the
Supreme Court has declined to consider constitutional claims before the
administrative process was completed. See Thunder Basin Coal Co. v. Reich,
510
U.S. 200, 215,
114 S. Ct. 771, 780 (1994) (holding that the district court did not
have subject-matter jurisdiction to hear a pre-enforcement due process challenge).
8
Case: 14-12144 Date Filed: 01/20/2015 Page: 9 of 11
The Court in Thunder Basin emphasized that the claims “c[ould] be meaningfully
addressed in the Court of Appeals” after final agency determination.
Id. Our own
Court’s decision in Doe v. FAA,
432 F.3d 1259 (11th Cir. 2005), also clarifies that
all constitutional claims must be funneled through the direct-appeal process after a
final agency action if that is the scheme created by Congress.
Id. at 1262–63. The
FTC Act provides for appellate review by the Courts of Appeals after the agency
action is complete, see 15 U.S.C. § 45(c), and similar to the challenger in Doe,
LabMD’s claims can be heard at that time.
LabMD cites National Parks Conservation Association v. Norton,
324 F.3d
1229, 1241 (11th Cir. 2003), to say that, absent an explicit provision limiting
constitutional review in the agency’s enabling statute, the federal courts should
always be able to hear well-pleaded complaints. Though it is true that in Norton
we addressed the merits of an equal-protection claim after finding that agency
action was not sufficiently final to confer jurisdiction over a connected APA claim,
nothing in that holding requires us to do the same here. Though there is tension
between Norton on one hand and Thunder Basin and Doe on the other, we
conclude that LabMD’s constitutional claims should be heard only upon
completion of the agency proceedings. We have consistently looked to how
“inescapably intertwined” the constitutional claims are to the agency proceeding,
reasoning that the harder it is to distinguish them, the less prudent it is to interfere
9
Case: 14-12144 Date Filed: 01/20/2015 Page: 10 of 11
in an ongoing agency process. See
Doe, 432 F.3d at 1263; Green v. Brantley,
981
F.2d 514, 521 (11th Cir. 1993) (declining to reach the merits of a constitutional
challenge that was “inescapably intertwined with a review of the procedures and
merits surrounding the [agency’s] order”). LabMD’s claims cannot now be heard
because the facts supporting them are indistinguishable from those relating to the
procedures and merits of the FTC action.
LabMD suggests that its First Amendment retaliation claim—alleging that
the FTC brought its Complaint to retaliate against LabMD for Mr. Daugherty’s
book— is less intertwined with the enforcement proceeding than its other
constitutional claims. This, LabMD contends, is because the retaliatory conduct
was complete at the moment the Complaint was filed. LabMD suggests that the
District Court need only examine the filing of the FTC’s Complaint to determine
whether it was retaliatory in violation of the First Amendment. Any later
developments in the administrative proceeding, LabMD reasons, have no bearing
on whether the filing of the Complaint itself was retaliatory. Thus, LabMD
concludes that the matters are not intertwined, and its retaliation claim should be
heard even before the administrative proceeding ends.
Even if we were to accept LabMD’s distinction as true, none of our cases
suggest that First Amendment retaliation claims must be treated differently than
other constitutional claims under Thunder Basin and Doe. We conclude that
10
Case: 14-12144 Date Filed: 01/20/2015 Page: 11 of 11
LabMD’s First Amendment claim must join its other claims to await appellate
review after the Commission’s proceedings are final, as Congress contemplated in
the FTC Act.
The District Court correctly held that it did not have jurisdiction over
LabMD’s claims. And until the administrative proceeding is complete, we too
have no jurisdiction to evaluate the merits. We AFFIRM the District Court’s
Order dismissing the case for lack of subject-matter jurisdiction.
11